5-butyl-3-(cyclohexanecarbonyl)-9-[1-(2,6-dimethylbenzoyl)piperidin-4-yl]-1-oxa-3,9-diazaspiro[5.5]undecan-2-one;5-butyl-9-[1-(2,6-dimethylbenzoyl)piperidin-4-yl]-3-[(1-hydroxycyclohexyl)methyl]-1-oxa-3,9-diazaspiro[5.5]undecan-2-one;1-[[5-butyl-9-[1-(2,6-dimethylbenzoyl)piperidin-4-yl]-2-oxo-1-oxa-3,9-diazaspiro[5.5]undecan-3-yl]methyl]cyclohexane-1-carbonitrile

C100H150N10O11 — CID 87925077

IUPAC5-butyl-3-(cyclohexanecarbonyl)-9-[1-(2,6-dimethylbenzoyl)piperidin-4-yl]-1-oxa-3,9-diazaspiro[5.5]undecan-2-one;5-butyl-9-[1-(2,6-dimethylbenzoyl)piperidin-4-yl]-3-[(1-hydroxycyclohexyl)methyl]-1-oxa-3,9-diazaspiro[5.5]undecan-2-one;1-[[5-butyl-9-[1-(2,6-dimethylbenzoyl)piperidin-4-yl]-2-oxo-1-oxa-3,9-diazaspiro[5.5]undecan-3-yl]methyl]cyclohexane-1-carbonitrile
SMILESCCCCC1CN(C(=O)C2CCCCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)cccc3C)CC1)CC2.CCCCC1CN(CC2(C#N)CCCCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)cccc3C)CC1)CC2.CCCCC1CN(CC2(O)CCCCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)cccc3C)CC1)CC2
InChIInChI=1S/C34H50N4O3.C33H49N3O4.C33H51N3O4/c1-4-5-12-28-23-38(25-33(24-35)15-7-6-8-16-33)32(40)41-34(28)17-21-36(22-18-34)29-13-19-37(20-14-29)31(39)30-26(2)10-9-11-27(30)3;1-4-5-14-27-23-36(30(37)26-12-7-6-8-13-26)32(39)40-33(27)17-21-34(22-18-33)28-15-19-35(20-16-28)31(38)29-24(2)10-9-11-25(29)3;1-4-5-12-27-23-36(24-32(39)15-7-6-8-16-32)31(38)40-33(27)17-21-34(22-18-33)28-13-19-35(20-14-28)30(37)29-25(2)10-9-11-26(29)3/h9-11,28-29H,4-8,12-23,25H2,1-3H3;9-11,26-28H,4-8,12-23H2,1-3H3;9-11,27-28,39H,4-8,12-24H2,1-3H3
InChIKeyOWTZIEDWHABURD-UHFFFAOYSA-N
MW1668.36 g/mol
LogP18.28
Rot. Bonds20

About 5-butyl-3-(cyclohexanecarbonyl)-9-[1-(2,6-dimethylbenzoyl)piperidin-4-yl]-1-oxa-3,9-diazaspiro[5.5]undecan-2-one;5-butyl-9-[1-(2,6-dimethylbenzoyl)piperidin-4-yl]-3-[(1-hydroxycyclohexyl)methyl]-1-oxa-3,9-diazaspiro[5.5]undecan-2-one;1-[[5-butyl-9-[1-(2,6-dimethylbenzoyl)piperidin-4-yl]-2-oxo-1-oxa-3,9-diazaspiro[5.5]undecan-3-yl]methyl]cyclohexane-1-carbonitrile

5-butyl-3-(cyclohexanecarbonyl)-9-[1-(2,6-dimethylbenzoyl)piperidin-4-yl]-1-oxa-3,9-diazaspiro[5.5]undecan-2-one;5-butyl-9-[1-(2,6-dimethylbenzoyl)piperidin-4-yl]-3-[(1-hydroxycyclohexyl)methyl]-1-oxa-3,9-diazaspiro[5.5]undecan-2-one;1-[[5-butyl-9-[1-(2,6-dimethylbenzoyl)piperidin-4-yl]-2-oxo-1-oxa-3,9-diazaspiro[5.5]undecan-3-yl]methyl]cyclohexane-1-carbonitrile (PubChem CID 87925077) has the molecular formula C100H150N10O11 and a molecular weight of 1668.36 g/mol. Its IUPAC name is 5-butyl-3-(cyclohexanecarbonyl)-9-[1-(2,6-dimethylbenzoyl)piperidin-4-yl]-1-oxa-3,9-diazaspiro[5.5]undecan-2-one;5-butyl-9-[1-(2,6-dimethylbenzoyl)piperidin-4-yl]-3-[(1-hydroxycyclohexyl)methyl]-1-oxa-3,9-diazaspiro[5.5]undecan-2-one;1-[[5-butyl-9-[1-(2,6-dimethylbenzoyl)piperidin-4-yl]-2-oxo-1-oxa-3,9-diazaspiro[5.5]undecan-3-yl]methyl]cyclohexane-1-carbonitrile.

Molecular Properties

Compound Name5-butyl-3-(cyclohexanecarbonyl)-9-[1-(2,6-dimethylbenzoyl)piperidin-4-yl]-1-oxa-3,9-diazaspiro[5.5]undecan-2-one;5-butyl-9-[1-(2,6-dimethylbenzoyl)piperidin-4-yl]-3-[(1-hydroxycyclohexyl)methyl]-1-oxa-3,9-diazaspiro[5.5]undecan-2-one;1-[[5-butyl-9-[1-(2,6-dimethylbenzoyl)piperidin-4-yl]-2-oxo-1-oxa-3,9-diazaspiro[5.5]undecan-3-yl]methyl]cyclohexane-1-carbonitrile
PubChem CID87925077
Molecular FormulaC100H150N10O11
Molecular Weight1668.36 g/mol
Exact Mass1667.15
IUPAC Name5-butyl-3-(cyclohexanecarbonyl)-9-[1-(2,6-dimethylbenzoyl)piperidin-4-yl]-1-oxa-3,9-diazaspiro[5.5]undecan-2-one;5-butyl-9-[1-(2,6-dimethylbenzoyl)piperidin-4-yl]-3-[(1-hydroxycyclohexyl)methyl]-1-oxa-3,9-diazaspiro[5.5]undecan-2-one;1-[[5-butyl-9-[1-(2,6-dimethylbenzoyl)piperidin-4-yl]-2-oxo-1-oxa-3,9-diazaspiro[5.5]undecan-3-yl]methyl]cyclohexane-1-carbonitrile
SMILESCCCCC1CN(C(=O)C2CCCCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)cccc3C)CC1)CC2.CCCCC1CN(CC2(C#N)CCCCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)cccc3C)CC1)CC2.CCCCC1CN(CC2(O)CCCCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)cccc3C)CC1)CC2
InChIInChI=1S/C34H50N4O3.C33H49N3O4.C33H51N3O4/c1-4-5-12-28-23-38(25-33(24-35)15-7-6-8-16-33)32(40)41-34(28)17-21-36(22-18-34)29-13-19-37(20-14-29)31(39)30-26(2)10-9-11-27(30)3;1-4-5-14-27-23-36(30(37)26-12-7-6-8-13-26)32(39)40-33(27)17-21-34(22-18-33)28-15-19-35(20-16-28)31(38)29-24(2)10-9-11-25(29)3;1-4-5-12-27-23-36(24-32(39)15-7-6-8-16-32)31(38)40-33(27)17-21-34(22-18-33)28-13-19-35(20-14-28)30(37)29-25(2)10-9-11-26(29)3/h9-11,28-29H,4-8,12-23,25H2,1-3H3;9-11,26-28H,4-8,12-23H2,1-3H3;9-11,27-28,39H,4-8,12-24H2,1-3H3
InChIKeyOWTZIEDWHABURD-UHFFFAOYSA-N
XLogP18.28
TPSA220.36 Ų
H-Bond Donors1
H-Bond Acceptors15
Rotatable Bonds20
Heavy Atoms121
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001668.36
LogP ≤ 518.28
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1015

Computed Properties (RDKit)

Structural Alerts{'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}

Analyze 5-butyl-3-(cyclohexanecarbonyl)-9-[1-(2,6-dimethylbenzoyl)piperidin-4-yl]-1-oxa-3,9-diazaspiro[5.5]undecan-2-one;5-butyl-9-[1-(2,6-dimethylbenzoyl)piperidin-4-yl]-3-[(1-hydroxycyclohexyl)methyl]-1-oxa-3,9-diazaspiro[5.5]undecan-2-one;1-[[5-butyl-9-[1-(2,6-dimethylbenzoyl)piperidin-4-yl]-2-oxo-1-oxa-3,9-diazaspiro[5.5]undecan-3-yl]methyl]cyclohexane-1-carbonitrile with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 5-butyl-3-(cyclohexanecarbonyl)-9-[1-(2,6-dimethylbenzoyl)piperidin-4-yl]-1-oxa-3,9-diazaspiro[5.5]undecan-2-one;5-butyl-9-[1-(2,6-dimethylbenzoyl)piperidin-4-yl]-3-[(1-hydroxycyclohexyl)methyl]-1-oxa-3,9-diazaspiro[5.5]undecan-2-one;1-[[5-butyl-9-[1-(2,6-dimethylbenzoyl)piperidin-4-yl]-2-oxo-1-oxa-3,9-diazaspiro[5.5]undecan-3-yl]methyl]cyclohexane-1-carbonitrile?
The IUPAC name of 5-butyl-3-(cyclohexanecarbonyl)-9-[1-(2,6-dimethylbenzoyl)piperidin-4-yl]-1-oxa-3,9-diazaspiro[5.5]undecan-2-one;5-butyl-9-[1-(2,6-dimethylbenzoyl)piperidin-4-yl]-3-[(1-hydroxycyclohexyl)methyl]-1-oxa-3,9-diazaspiro[5.5]undecan-2-one;1-[[5-butyl-9-[1-(2,6-dimethylbenzoyl)piperidin-4-yl]-2-oxo-1-oxa-3,9-diazaspiro[5.5]undecan-3-yl]methyl]cyclohexane-1-carbonitrile (CID 87925077) is 5-butyl-3-(cyclohexanecarbonyl)-9-[1-(2,6-dimethylbenzoyl)piperidin-4-yl]-1-oxa-3,9-diazaspiro[5.5]undecan-2-one;5-butyl-9-[1-(2,6-dimethylbenzoyl)piperidin-4-yl]-3-[(1-hydroxycyclohexyl)methyl]-1-oxa-3,9-diazaspiro[5.5]undecan-2-one;1-[[5-butyl-9-[1-(2,6-dimethylbenzoyl)piperidin-4-yl]-2-oxo-1-oxa-3,9-diazaspiro[5.5]undecan-3-yl]methyl]cyclohexane-1-carbonitrile.
What is the SMILES notation for 5-butyl-3-(cyclohexanecarbonyl)-9-[1-(2,6-dimethylbenzoyl)piperidin-4-yl]-1-oxa-3,9-diazaspiro[5.5]undecan-2-one;5-butyl-9-[1-(2,6-dimethylbenzoyl)piperidin-4-yl]-3-[(1-hydroxycyclohexyl)methyl]-1-oxa-3,9-diazaspiro[5.5]undecan-2-one;1-[[5-butyl-9-[1-(2,6-dimethylbenzoyl)piperidin-4-yl]-2-oxo-1-oxa-3,9-diazaspiro[5.5]undecan-3-yl]methyl]cyclohexane-1-carbonitrile?
The canonical SMILES for 5-butyl-3-(cyclohexanecarbonyl)-9-[1-(2,6-dimethylbenzoyl)piperidin-4-yl]-1-oxa-3,9-diazaspiro[5.5]undecan-2-one;5-butyl-9-[1-(2,6-dimethylbenzoyl)piperidin-4-yl]-3-[(1-hydroxycyclohexyl)methyl]-1-oxa-3,9-diazaspiro[5.5]undecan-2-one;1-[[5-butyl-9-[1-(2,6-dimethylbenzoyl)piperidin-4-yl]-2-oxo-1-oxa-3,9-diazaspiro[5.5]undecan-3-yl]methyl]cyclohexane-1-carbonitrile is CCCCC1CN(C(=O)C2CCCCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)cccc3C)CC1)CC2.CCCCC1CN(CC2(C#N)CCCCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)cccc3C)CC1)CC2.CCCCC1CN(CC2(O)CCCCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)cccc3C)CC1)CC2.
What is the InChIKey of 5-butyl-3-(cyclohexanecarbonyl)-9-[1-(2,6-dimethylbenzoyl)piperidin-4-yl]-1-oxa-3,9-diazaspiro[5.5]undecan-2-one;5-butyl-9-[1-(2,6-dimethylbenzoyl)piperidin-4-yl]-3-[(1-hydroxycyclohexyl)methyl]-1-oxa-3,9-diazaspiro[5.5]undecan-2-one;1-[[5-butyl-9-[1-(2,6-dimethylbenzoyl)piperidin-4-yl]-2-oxo-1-oxa-3,9-diazaspiro[5.5]undecan-3-yl]methyl]cyclohexane-1-carbonitrile?
The InChIKey is OWTZIEDWHABURD-UHFFFAOYSA-N. The full InChI is InChI=1S/C34H50N4O3.C33H49N3O4.C33H51N3O4/c1-4-5-12-28-23-38(25-33(24-35)15-7-6-8-16-33)32(40)41-34(28)17-21-36(22-18-34)29-13-19-37(20-14-29)31(39)30-26(2)10-9-11-27(30)3;1-4-5-14-27-23-36(30(37)26-12-7-6-8-13-26)32(39)40-33(27)17-21-34(22-18-33)28-15-19-35(20-16-28)31(38)29-24(2)10-9-11-25(29)3;1-4-5-12-27-23-36(24-32(39)15-7-6-8-16-32)31(38)40-33(27)17-21-34(22-18-33)28-13-19-35(20-14-28)30(37)29-25(2)10-9-11-26(29)3/h9-11,28-29H,4-8,12-23,25H2,1-3H3;9-11,26-28H,4-8,12-23H2,1-3H3;9-11,27-28,39H,4-8,12-24H2,1-3H3.
What are the key properties of 5-butyl-3-(cyclohexanecarbonyl)-9-[1-(2,6-dimethylbenzoyl)piperidin-4-yl]-1-oxa-3,9-diazaspiro[5.5]undecan-2-one;5-butyl-9-[1-(2,6-dimethylbenzoyl)piperidin-4-yl]-3-[(1-hydroxycyclohexyl)methyl]-1-oxa-3,9-diazaspiro[5.5]undecan-2-one;1-[[5-butyl-9-[1-(2,6-dimethylbenzoyl)piperidin-4-yl]-2-oxo-1-oxa-3,9-diazaspiro[5.5]undecan-3-yl]methyl]cyclohexane-1-carbonitrile?
5-butyl-3-(cyclohexanecarbonyl)-9-[1-(2,6-dimethylbenzoyl)piperidin-4-yl]-1-oxa-3,9-diazaspiro[5.5]undecan-2-one;5-butyl-9-[1-(2,6-dimethylbenzoyl)piperidin-4-yl]-3-[(1-hydroxycyclohexyl)methyl]-1-oxa-3,9-diazaspiro[5.5]undecan-2-one;1-[[5-butyl-9-[1-(2,6-dimethylbenzoyl)piperidin-4-yl]-2-oxo-1-oxa-3,9-diazaspiro[5.5]undecan-3-yl]methyl]cyclohexane-1-carbonitrile has a molecular weight of 1668.36 g/mol, XLogP of 18.28, 20 rotatable bonds, 1 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for 5-butyl-3-(cyclohexanecarbonyl)-9-[1-(2,6-dimethylbenzoyl)piperidin-4-yl]-1-oxa-3,9-diazaspiro[5.5]undecan-2-one;5-butyl-9-[1-(2,6-dimethylbenzoyl)piperidin-4-yl]-3-[(1-hydroxycyclohexyl)methyl]-1-oxa-3,9-diazaspiro[5.5]undecan-2-one;1-[[5-butyl-9-[1-(2,6-dimethylbenzoyl)piperidin-4-yl]-2-oxo-1-oxa-3,9-diazaspiro[5.5]undecan-3-yl]methyl]cyclohexane-1-carbonitrile is sourced from PubChem (CID 87925077), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).